GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Net Income (Continuing Operations)

Baskhanbiopharma (XKRX:354390) Net Income (Continuing Operations) : ₩2,797 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Baskhanbiopharma's Net Income (Continuing Operations) for the six months ended in Dec. 2024 was ₩2,797 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,797 Mil.

Baskhanbiopharma Net Income (Continuing Operations) Historical Data

The historical data trend for Baskhanbiopharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Net Income (Continuing Operations) Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
-309.21 369.46 167.67 2,778.44 2,797.45

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations) -309.21 369.46 167.67 2,778.44 2,797.45

Baskhanbiopharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,797 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baskhanbiopharma  (XKRX:354390) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Baskhanbiopharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:018620 XKRX:318010 XKRX:034940 XKRX:233250 XKRX:336040 XKRX:018680 XKRX:900120 XKRX:053950 XKRX:200230 XKRX:314140 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Website
https://www.baskhanbio.com
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines